Amundi Reduces Position in 10x Genomics, Inc. (NASDAQ:TXG)
Amundi trimmed its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 98.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,988 shares of the company’s stock after selling 98,904 shares during the period. Amundi’s holdings in 10x Genomics were worth $31,000 as of its most recent SEC filing. Other hedge funds […]
Amundi trimmed its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 98.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,988 shares of the company’s stock after selling 98,904 shares during the period. Amundi’s holdings in 10x Genomics were worth $31,000 as of its most recent SEC filing. Other hedge funds […]
